GUERRIERI, Davide
 Distribuzione geografica
Continente #
NA - Nord America 1.206
EU - Europa 709
AS - Asia 128
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 2.048
Nazione #
US - Stati Uniti d'America 1.200
GB - Regno Unito 211
IT - Italia 173
DE - Germania 95
CN - Cina 58
SE - Svezia 58
FR - Francia 54
UA - Ucraina 32
PL - Polonia 30
SG - Singapore 21
FI - Finlandia 19
HK - Hong Kong 17
TR - Turchia 13
BG - Bulgaria 11
IN - India 11
BE - Belgio 8
RU - Federazione Russa 7
CA - Canada 5
IE - Irlanda 4
LT - Lituania 3
IR - Iran 2
MY - Malesia 2
NL - Olanda 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
DK - Danimarca 1
ID - Indonesia 1
JP - Giappone 1
MX - Messico 1
RS - Serbia 1
TN - Tunisia 1
TZ - Tanzania 1
Totale 2.048
Città #
Fairfield 179
Southend 178
Chandler 123
Woodbridge 120
Ashburn 102
Houston 77
Ann Arbor 66
Jacksonville 64
Seattle 62
Cambridge 55
Wilmington 54
Dearborn 42
Frankfurt am Main 42
Nyköping 42
Modena 40
Kraków 28
Hong Kong 17
Fremont 15
Princeton 13
Grafing 11
New York 11
San Diego 11
Sofia 11
Beijing 10
Eugene 10
Helsinki 10
London 9
Redwood City 8
Shanghai 8
Brussels 7
Izmir 7
Bologna 6
Milan 6
Rome 6
San Mateo 6
Boardman 5
Bremen 5
Singapore 5
Des Moines 4
Dublin 4
Los Angeles 4
Toronto 4
Detroit 3
Loano 3
Parma 3
Valenza 3
Albino 2
Auburn Hills 2
Casagiove 2
Cattolica 2
Dong Ket 2
Indiana 2
Jinan 2
Kilburn 2
Kunming 2
Mirandola 2
Monmouth Junction 2
Nanjing 2
Nürnberg 2
Oleggio 2
Palermo 2
Saint Petersburg 2
Scandicci 2
Treia 2
Warsaw 2
Amsterdam 1
Ardabil 1
Baotou 1
Belgrade 1
Benevento 1
Cadeo 1
Cagliari 1
Castelfiorentino 1
Chiavari 1
Chiswick 1
Copenhagen 1
Crotone 1
Cuauhtémoc 1
Dalian 1
Dar es Salaam 1
Eppelheim 1
Filottrano 1
Florence 1
Giulianova 1
Groningen 1
Guangzhou 1
Hangzhou 1
Harrogate 1
Hefei 1
Heze 1
Hounslow 1
Jakarta 1
Leawood 1
Livorno 1
Louvain 1
Marzabotto 1
Misterbianco 1
Mountain View 1
Nanchang 1
Nanning 1
Totale 1.572
Nome #
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 279
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 278
Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and-resistant human ovarian cancer cells 212
Spermidine/spermine N1-acetyltranferasemodulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistanthuman ovarian cancer cell lines 209
Structure-Based Selectivity Optimization of Piperidine–Pteridine Derivatives as Potent Leishmania Pteridine Reductase Inhibitors 200
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells 194
Biochemical effects of riluzole on Leishmania parasites 181
Ligand-Based Virtual Screening and ADME-Tox Guided Approach to Identify Triazolo-quinoxalines as Folate Cycle Inhibitors. 175
Collateral sensitivity to novel folate cycle inhibitors enhances cisplatin effectiveness against human ovarian cancer cells. 132
SSAT modulation by putative regulators of folate cycle enzymes expression in cisplatin-sensitive and –resistant human ovarian cancer cell lines. 118
Erratum: Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 34 (E542-E549) DOI: 10.1073/pnas.1104829108) 100
Totale 2.078
Categoria #
all - tutte 7.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020450 40 18 18 37 56 56 71 50 43 15 22 24
2020/2021369 32 21 30 44 44 27 16 43 13 50 32 17
2021/2022258 12 24 29 9 8 24 11 7 20 27 53 34
2022/2023284 30 40 26 31 36 42 1 34 24 5 6 9
2023/2024202 5 10 15 14 70 27 10 9 3 6 17 16
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 2.078